Peter Dowd MP: written questions

Peter Dowd MP: full overview

4 Jul 2025–3 Jul 2026

How these years work

Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.

Compare reporting years, sessions and IPSA financial years.

Written questions: dates and coverage

Source checked
21 Nov 2026
Last successful import
21 Nov 2026
Records dated through
20 Nov 2026
Selected period
Reporting year 2: 4 Jul 2025 to 3 Jul 2026
Completeness
Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.

How to read these datesOfficial source

Understand written questions, dates and answers.

Read what this MP said, asked and contributed in Parliament.

3 published records · newest first.

Written questions

  • Multiple Sclerosis: Health ServicesDepartment of Health and Social CareTabled 9 Dec 2025AnsweredUIN 98439More

    Question: To ask the Secretary of State for Health and Social Care, what data his department collects to monitor potential inequalities in multiple sclerosis care access; and how those findings are used to inform policy and service delivery improvements.

    Answer: The Department does not collect patient-level clinical data directly but works with NHS England and other bodies to monitor inequalities in access to multiple sclerosis (MS) services through a range of national programmes and datasets.The UK Multiple Scle...

    Answered 5 Jan 2026

    Original Parliament record
  • Cannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 Nov 2025AnsweredUIN 92020More

    Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resis

    Answer: The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is funding two trials to investigate the safety and efficacy of cannabinoid treatments for drug-resistant epilepsy in both adults and children...

    Answered 25 Nov 2025

    Original Parliament record
  • Cannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 Nov 2025AnsweredUIN 92019More

    Question: To ask the Secretary of State for Health and Social Care, whether he plans to bring responsibility for medical cannabis policy and governance to his Department in line with Schedule 2 medicines.

    Answer: The Home Office is the lead department for controlled drug legislation, whilst the Department of Health and Social Care and its Arm's Length Bodies lead on healthcare and the regulation of medicines. This framework applies to all drugs under Schedules 1 t...

    Answered 25 Nov 2025

    Original Parliament record
Explore activity by topic or department

Written questions by answering department

4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.

View as listDepartment for Transport: 1Department for Transport1Department for Work and Pensions: 1Department for Work and Pensions1Department of Health and Social Care: 3Department of Health and Social…3Home Office: 1Home Office1
What this shows and doesn't show
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality. Published records do not measure effort or effectiveness. Methodology.
Department or topicPublished records
Department for Transport1
Department for Work and Pensions1
Department of Health and Social Care3
Home Office1

Published records only — not a full account of an MP’s work. How we work →